Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Towards carbon-neutral buildings – Caverion and ABB to announce new collaboration

Caverion Corporation Press release 8 September 2022 at 11.15 a.m. EESTTowards carbon-neutral buildings – Caverion and ABB to announce new collaboration Caverion and ABB have today announced an agreement to accelerate the development of energy efficient and sustainable buildings. The aim of the collaboration is to jointly offer customers advanced, smart solutions for achieving carbon-neutral buildings and reaching their sustainability targets. Bringing together ABB’s technology solutions, including Mission to Zero™,  and Caverion’s

Wake Forest Institute for Regenerative Medicine Welcomes PHI

Phase Holographic Imaging (PHI) visits the Wake Forest Institute for Regenerative Medicine (WFIRM) to finalize an agreement concerning the automation of advanced quality control in large-scale biomanufacturing of regenerative therapies. Regenerative medicine therapies cure patients with previously untreatable and life-threatening diseases using laboratory cultured cells, tissue or organs. The success of these “miracle cures” have led to a flood of investments. According to the 2021 annual report of the Alliance for Regenerative Medi­cine , 73 billion USD

UNION therapeutics presents new data on orismilast at the 31[st] EADV Congress supporting orismilast’s potential as a first-in-class or best-in-class treatment for certain immunological diseases

· Preclinical data presented in the oral presentation demonstrate that orismilast is a potent inhibitor of phosphodiesterase type-4 (PDE4), and that orismilast more selectively inhibit PDE4B and PDE4D subtypes which are considered more relevant in the treatment of immunological diseases · Phase 2a data support development of orismilast modified release (MR) tablet to improve the tolerability of orismilast which had demonstrated proof of concept in moderate to severe psoriasis in an immediate release (IR) tablet · Data presented at EADV support orismilast potential as a first-in-class

Wärtsilä to provide service for six Nature Energy biogas upgrading plants

Wärtsilä Corporation, Press release, 8 September at 11.00 AM EESTThe technology group Wärtsilä has signed a two-year tailored Service Agreement  with Denmark based Nature Energy, a leading operator of biogas upgrading facilities. The agreement covers six existing biogas plants in various parts of Denmark, all of which feature Wärtsilä biogas upgrading technology (Puregas) . The agreement was signed in July 2022. Special features of the agreement include an annual safety check, a know-how service that analyses operations to provide

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 177 - 8 SEPTEMBER 2022 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 158/22. A/S Motortramp participates in NORDEN’s share buy-back program by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in NORDEN.     Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor

Muvon Therapeutics Announces Successful Phase I Clinical Study in Female Patients with Stress Urinary Incontinence using a Novel Regenerative Cell Therapy

Zurich, Switzerland, September 8, 2022 -- Muvon Therapeutics AG, an innovative clinical-stage biotechnology company announced results from a Phase I clinical trial. This first study evaluating a proprietary cell therapy platform demonstrated the safety, feasibility and potential efficacy of autologous skeletal muscle injections into the bladder sphincter of women suffering from Stress Urinary Incontinence with the goal of naturally restoring strength and function over 6 months.Stress Urinary Incontinence (SUI) is defined as the complaint of any involuntary loss of urine on effort or

Color Line improves the energy efficiency of its vessels with Elogrid

Color Line has ordered the Elogrid solution from Elomatic for two of its passenger car ferries to improve their energy efficiency. The Elogrid grid design for thruster openings reduces the additional resistance of vessels. This reduces fuel consumption and carbon dioxide emissions. Elogrid also enhances the performance of thruster tunnels, which leads to better maneuverability.Norwegian shipping company Color Line has ordered the Elogrid solution developed by Elomatic for its M/S Superspeed 1 and M/S Superspeed 2 passenger car ferries. Elogrid will be installed in early 2023 during

Almost a third of energy companies’ digital transformation efforts driven by need for tighter integration and collaboration

But nearly three-in-ten oil, gas and utility companies say inability to define and measure ROI remains a barrier to adoptionLondon, UK, September 8 2022 – More than three-in-ten (31%) oil, gas and utility organisations worldwide cite tighter integration and collaboration across functions among the top two drivers for the adoption of enterprise software systems, while 30% reference better project management, 29% improved asset lifecycle management and 29% improved operational efficiency. These were among the highlights of new research commissioned by IFS , polling

Royal Joh. Enschedé steps into the world of NFTs with PROxID and Concordium blockchain collaboration

September 8, 2022, Switzerland and the Netherlands - Royal Joh. Enschedé, a 320-year-old Dutch printing company specialized in banknotes, postage stamps, tax labels, passports and visas, is teaming up with PROxID and Concordium blockchain to connect the world between security print products, NFTs and the metaverse.   Dutch software developer PROxID is building an NFT platform on the layer-1 blockchain with the integrated ID framework of the Swiss foundation Concordium, a market leader in securing digital assets via the ID layer. Concordium’s unique blockchain-based ID

Ampilio, subisiary of SpectrumOne, signs partnership agreement with the Danish e-commerce funding company Mxney ApS.

Ampilio, subsidiary of SpectrumOne, has signed a partnership agreement with the Danish e-commerce funding company Mxney ApS. Mxney funds e-commerce businesses and makes it possible for them to reach their goals in a shorter time and with a proven track record. They have funded more than 100 e-commerce companies with more than DKK 50 million. Mxney´s offer is not just funding but also offer their expertise in the best growth tactics based on insight, implementation and hundreds of successful cases. The collaboration between Ampilio and Mxney are in the areas of Ampilio’s core business

Stendörren to be included in the EPRA index

Press release 8 September 2022 EPRA (The European Public Real Estate Association) has published that Stendörren will be included in the EPRA index. The FTSE EPRA Nareit Global Real Estate Index (EPRA index) is a leading global index for listed real estate investments and consists of approximately 500 real estate companies. "We are glad that Stendörren will be included in the EPRA index. This means that we can reach a broader group of international investors, which creates value for the company and our shareholders ", says Erik Ranje, CEO of Stendörren. EPRA announces

Flowscape wins deal for hybrid office solution

Flowscape's solution for the hybrid office  wins a contract with a municipal company in Sweden. First year revenue is 645,000 SEK (60,320 Euro) and thereafter 145,600 SEK (13,600 Euro) annually recurring."Once again, we are winning business thanks to the fact that we can deliver a complete solution with both software and hardware, regardless of what IT environment or requirements the customer has. This customer already uses Flowscape's solution for booking workplaces and now wanted to expand with room booking panels, room booking and smart sensors. We are

Epiroc issues green bonds amounting to SEK 2 billion

Stockholm, Sweden: Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has issued green bonds to finance sustainable investments, expenditures, and R&D.Epiroc yesterday issued SEK 2 billion in green bonds with considerable investor interest and an order book exceeding SEK 3 billion. The tenor is five years, and the bond has two tranches, one fixed and one floating. The fixed tranche of SEK 1.5 billion has a coupon of 4.155% and the floating tranche of SEK 0.5 billion was priced at 3M STIBOR plus 1.20%. The bond is issued under Epiroc’s

Results from study with Episealer® Knee implant accepted for presentation at Australian and New Zealand orthopaedic congress

Episurf Medical (Nasdaq: EPIS B) today announces that the abstract “Episealer, a mini metal implant for chondral injuries in the knee. A prospective single surgeon case series”, has been accepted for a podium presentation at the combined Australian and New Zealand Knee Societies meeting, which will take place in Queenstown, New Zealand, on October 27 - 29, 2022. The presentation will be held by Prof. Karl Eriksson from Stockholm South Hospital and The Karolinska Institute, Stockholm, Sweden. The abstract reports on the clinical outcome for patients having undergone treatment with Episurf

Medivir to present data on additive efficacy of fostrox in combination with anti-PD1 in nonclinical tumor models at the SITC 2022 Annual Meeting

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, today announces that an abstract about its lead program fostroxacitabine bralpamide (fostrox) and the potential efficacy in primary liver cancer has been accepted for presentation at the at the SITC 37th Annual Meeting, held November 10-12, 2022, in Boston, USA. The abstract, titled “Fostrox (MIV-818) in combination with anti-PD-1 shows increased efficacy in nonclinical tumour models in vivo” will be presented at the

Changes in Dustin’s group management team – increased focus on synergies and SMB in Benelux

To enable further synergies and to increase the pace in the implementation of the Nordic model for small and medium sized businesses in the Benelux, Dustin establishes a common group organisation for Operations and one for the segment small and medium sized businesses. Alexandra Fürst, currently COO Nordic, will be responsible for Operations and Rebecca Tallmark, currently EVP SMB Nordic, will be responsible for SMB. As an effect Morten Jakobi, EVP SMB Benelux, and Gijsbert Geerders, COO Benelux, will leave the group management team but stay in the company in other roles.- During the year

Gaming Innovation Group formalise agreement with Crabsports for Maryland, US

Following a head of terms signed in June (ref. announcement on 7 June 2022), Gaming Innovation Group (GiG) has now formalised the agreement to provide its award winning Platform and Sportsbook, to US based brand Crabsports. This deal marks the first deal of its kind in the US for GiG following the acquisition of Sportnco earlier this year, providing an example of the potential contained within the newly combined product offering.  Powered by leading technology and flexible architecture, this turnkey solution includes the technical platform and Sportsbook, all powered by GiG’s unique

SkartaNYAB Oyj - Managers' Transactions

SkartaNYAB PlcMANAGERS' TRANSACTIONS08 September 2022 at 09:30SkartaNYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Johan LarssonPosition: Chief Executive Officer Issuer: SkartaNYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 19298/5/6____________________________________________ Transaction date: 2022-09-05Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000153515Nature of the transaction: ACQUISITION

OKEA ASA - ANNOUNCEMENT TO THE OSE ON BEHALF OF SHAREHOLDER

(Trondheim, 8 September 2022) OKEA ASA (OSE: OKEA): OKEA ASA (“OKEA” or the “Company”) has today been informed by its shareholder BCPR Pte Ltd (BCPR) of a contemplated divestment of shares in OKEA, representing up to approximately 2.8% of the total outstanding shares in the Company. Please find the information from BCPR below and in the attachment.Message from BCPR (Shareholder): Contemplated divestment of shares in OKEA ASA BCPR Pte Ltd (“BCPR”), a wholly owned subsidiary of Bangchak Corporation, hereby announces its intention to divest a number of shares it holds in OKEA ASA (“OKEA”)

Cereno Scientific’s patent protection for drug candidate CS1 expands in Mexico through its second patent family

Cereno Scientific (XSAT: CRNO B) today announced that drug candidate CS1’s second patent family has obtained a granted patent in Mexico. This strengthens and broadens the intellectual property right (IPR) for Cereno’s Phase II drug candidate CS1 which is being developed for the treatment of rare disease pulmonary arterial hypertension (PAH).“We are building a strong intellectual property rights position for CS1. This is an important part of our efforts to protect our innovations and strengthen the commercial positioning of the drug candidate,” said Sten R. Sörensen, CEO at Cereno. CS1’s

BioStock: Election issues affecting the life science industry

Life science is not often mentioned in the election debate, but many of the major election issues may affect the industry's continued progress. BioStock talked to Anders Blanck, CEO of LIF, and Jenni Nordborg, national life science coordinator, to find out which election issues they believe are the most important for the sector.Read the full article about the election issues affecting the life science industry on biostock.se/en/: https://www.biostock.se/en/2022/09/issues-affecting-the-industry/  This is a press release from BioStock -

AFRY acted as technical advisor to Infinity group for Africa’s largest renewable energy transaction

AFRY has supported Infinity group and Africa Finance Corporation (AFC) in securing the acquisition of Lekela Power.In July this year Infinity group and AFC signed an agreement to buy Lekela Power from Actis, a global investor in sustainable infrastructure, and a consortium lead by Mainstream Renewable Power. The deal will be finalised after regulatory approvals and fulfilment of customary closing conditions. Established in 2015, Lekela Power today represents the largest Independent Power Producer focused on renewables in Africa. Lekela’s portfolio comprises several operational wind

Wärtsilä and CLdN cooperate in building of innovative hybrid RoRo vessels

Wärtsilä Corporation, Trade press release, 8 September 2022 at 9.00 AM EESTThe technology group Wärtsilä and logistics provider CLdN have jointly developed an innovative hybrid design for two new RoRo vessels. The propulsion arrangement is such that the ships can operate as gas/diesel-mechanical vessel now, or in the future as gas/diesel-electric vessel. The vessels are being built at Hyundai Mipo Dockyards in Korea. The Wärtsilä hybrid system  includes Energy Storage Systems, two large PTO/PTI generators and electric motors, multidrive converters, and the

There are no items matching the current filter
There are no more items matching the current filter
Back to top